As of Oct 02
| +1.76 / +1.39%|
The 29 analysts offering 12-month price forecasts for Bayer have a median target of 157.39, with a high estimate of 184.18 and a low estimate of 124.54. The median estimate represents a +22.55% increase from the last price of 128.43.
The current consensus among 30 polled investment analysts is to Buy stock in Bayer. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.